Maternal serum levels of total activin-A in first-trimester trisomy 21 pregnancies

被引:12
作者
Spencer, K
Liao, AW
Skentou, H
Ong, CYT
Nicolaides, KH
机构
[1] Harold Wood Hosp, Dept Clin Biochem, Endocrine Unit, Romford RM3 0BE, Essex, England
[2] Kings Coll Hosp London, Harris Birthright Res Ctr Fetal Med, London SE5 8RX, England
关键词
prenatal screening; Down syndrome; inhibin; free beta-hCG; PAPP-A;
D O I
10.1002/pd.53
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Maternal serum total activin-A concentration was measured in 45 pregnancies affected by trisomy 21 and il 93 control unaffected pregnancies at 10-14 weeks of gestation. In the trisomy 21 pregnancies total activin-A concentration was significantly higher (1.36 MoM of the unaffected pregnancies) and in 16% of cases the level was above the 95th centile of normal. The log(10) SD for the control group and the trisomy 21 group were 0.17 and 0.22. respectively. The median pregnancy associated plasma protein-A (PAPP-A) in this trisomy 21 series was 0.49 and for free beta -hCG was 2.05. In the trisomy group there were significant positive associations between total activin-A and PAPP-A (0.6071) and free beta -hCG (0.4255). The low median difference and the high overlap in values between trisomic and unaffected pregnancies make total activin-A of little practical use in first-trimester screening for trisomy 21. Copyright (C) 2001 John Wiley & Sons, Ltd.
引用
收藏
页码:270 / 273
页数:4
相关论文
共 50 条
  • [41] How Effective Is First-Trimester Screening for Trisomy 21 Based on Ultrasound Only?
    Wiechec, Marcin
    Knafel, Anna
    Nocun, Agnieszka
    Matyszkiewicz, Anna
    Juszczak, Magdalena
    Wiercinska, Ewa
    Latala, Emilia
    FETAL DIAGNOSIS AND THERAPY, 2016, 39 (02) : 105 - 112
  • [42] The impact of introducing combined first-trimester trisomy 21 screening in the French population
    Royere, Dominique
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2016, 26 (03) : 492 - 497
  • [43] First-trimester maternal serum biomarkers and the risk of cerebral palsy
    Peris, Monique
    Reid, Susan M.
    Dobie, Stephen
    Bonacquisto, Leo
    Shepherd, Daisy A.
    Amor, David J.
    DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2021, 63 (02) : 183 - 189
  • [44] The Values of First-trimester Maternal Serum Markers in Predicting Poor Obstetric Outcomes
    Baran, Safak Yilmaz
    Kalayci, Hakan
    Durdag, Gulsen Dogan
    Simsek, Seda Yuksel
    Yetkinel, Selcuk
    Simsek, Erhan
    ISTANBUL MEDICAL JOURNAL, 2019, 20 (04): : 325 - 329
  • [45] Maternal weight correction of maternal serum PAPP-A and free β-hCG MoM when screening for trisomy 21 in the first trimester of pregnancy
    Spencer, K
    Bindra, R
    Nicolaides, KH
    PRENATAL DIAGNOSIS, 2003, 23 (10) : 851 - 855
  • [46] First-trimester maternal serum human thyroid-stimulating hormone in chromosomally normal and Down syndrome pregnancies
    Weinans, MJN
    Pratt, JJ
    de Wolf, BTHM
    Mantingh, A
    PRENATAL DIAGNOSIS, 2001, 21 (09) : 723 - 725
  • [47] First-trimester urine free beta hCG, beta core, and total oestriol in pregnancies affected by Down's syndrome: Implications for first-trimester screening with nuchal translucency and serum free beta hCG
    Spencer, K
    Noble, P
    Snijders, RJM
    Nicolaides, KH
    PRENATAL DIAGNOSIS, 1997, 17 (06) : 525 - 538
  • [48] Maternal weight and ethnic adjustment within a first-trimester Down syndrome and trisomy 18 screening program
    Krantz, DA
    Hallahan, TW
    Macri, VJ
    Macri, JN
    PRENATAL DIAGNOSIS, 2005, 25 (08) : 635 - 640
  • [49] Correlation between First-Trimester Maternal Serum Markers, Second-Trimester Uterine Artery Doppler Indices and Pregnancy Outcome
    Dane, Banu
    Dane, Cem
    Kiray, Murat
    Cetin, Ahmet
    Koldas, Macit
    Erginbas, Murat
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2010, 70 (02) : 126 - 131
  • [50] First-Trimester and Second-Trimester Maternal Serum Biomarkers as Predictors of Placental Abruption
    Ananth, Cande V.
    Wapner, Ronald J.
    Ananth, Srinidhi
    D'Alton, Mary E.
    Vintzileos, Anthony M.
    OBSTETRICS AND GYNECOLOGY, 2017, 129 (03) : 465 - 472